Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 147.65 million compared to CNY 189.15 million a year ago. Net income was CNY 2.35 million compared to CNY 8.79 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.23 HKD | +0.45% | 0.00% | -12.55% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.55% | 833M | |
+10.23% | 9.11B | |
-10.76% | 5.21B | |
+51.58% | 4.83B | |
+12.50% | 4.09B | |
-20.70% | 2.35B | |
+12.83% | 2.32B | |
+19.51% | 2.27B | |
-29.65% | 2.19B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 1349 Stock
- News Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024